Поиск

Telcagepant does not reduce exercise tolerance in patients with exercise induced myocardial ischemia

Ho A.P., Chaitman B.R., Behm M.O., Rowe J.F., Palcza J.S., Laethem T., Heirman I., Panebianco D.L., Moiseev V.S., Martsevich S.Y., Free A.L., Bittar N., Chrysant S.G., Kobalava Z.D., Ho T.W., Chodakewitz J.A., Murphy M.G., Blanchard R.L.

Telcagepant does not reduce exercise tolerance in patients with exercise induced myocardial ischemia

Ho A.P., Chaitman B.R., Behm M.O., Rowe J.F., Palcza J.S., Laethem T., Heirman I., Panebianco D.L., Moiseev V.S., Martsevich S.Y., Free A.L., Bittar N., Chrysant S.G., Kobalava Z.D., Ho T.W., Chodakewitz J.A., Murphy M.G., Blanchard R.L.

PEMBROLIZUMAB VERSUS PACLITAXEL FOR PREVIOUSLY TREATED, ADVANCED GASTRIC OR GASTRO-OESOPHAGEAL JUNCTION CANCER (KEYNOTE-061): A RANDOMISED, OPEN-LABEL, CONTROLLED, PHASE 3 TRIAL

SHITARA, K., OHTSU, A., ÖZGÜROĞLU, M., BANG, Y.J., DI BARTOLOMEO, M., MANDALÀ, M., RYU, M.H.., FORNARO, L., OLESIŃSKI, T., CAGLEVIC, C., CHUNG, H.C., MURO, K., GOEKKURT, E., MANSOOR, W., MCDERMOTT, R.S., SHACHAM-SHMUELI, E., CHEN, X., MAYO, C., KANG, S.P., FUCHS, C.S., LERZO, G., O'CONNOR, J.M., MENDEZ, G.A., LYNAM, J., TEBBUTT, N., WONG, M., STRICKLAND, A., KARAPETIS, C., GOLDSTEIN, D., VASEY, P., VAN LAETHEM, J.L., VAN CUTSEM, E., BERRY, S., VINCENT, M., MULLER, B., REY, F., ZAMBRANO, A., GUERRA, J., KROGH, M., BAEKSGAARD, L., YILMAZ, M., ELME, A., MAGI, A., AUVINEN, P., ALANKO, T., MOEHLER, M., KUNZMANN, V., SEUFFERLEIN, T., THUSS-PATIENCE, P., HOEHLER, T., HAAG, G., AL-BATRAN, S.E., CASTRO, H., LOPEZ, K., AGUILAR VASQUEZ, M., SANDOVAL, M., LAM, K.O., CUFFE, S., KELLY, C., GEVA, R., HUBERT, A., BENY, A., BRENNER, B., GIUSEPPE, A., FALCONE, A., MAIELLO, E., PASSALACQUA, R., MONTESARCHIO, V., HARA, H., CHIN, K., NISHINA, T., KOMATSU, Y., MACHIDA, N., HIRONAKA, S., SATOH, T., TAMURA, T., SUGIMOTO, N., CHO, H., OMURO, Y., KATO, K., GOTO, M., HYODO, I., YOSHIDA, K., BABA, H., ESAKI, T., FURUSE, J., WAN MOHAMMED, W.Z., HERNANDEZ HERNANDEZ, C., CASAS GARCIA, J., DOMINGUEZ ANDRADE, A., CLARKE, K., HJORTLAND, G., GLENJEN, N., KUBIATOWSKI, T., JACEK, J., WOJTUKIEWICZ, M., LAZAREV, S., LANCUKHAY, Y., AFANASAYEV, S., MOISEYENKO, V., KOSTOROV, V., PROTSENKO, S., SHIRINKIN, V., SAKAEVA, D., FADEEVA, N., YONG, W.P., ROBERTSON, B., NG, C.H.M., ROBERTSON, B., RAPAPORT, B., COHEN, G., DREOSTI, L., RUFF, P., JACOBS, C., LANDERS, G., SZPAK, W., ROH, S.Y., LEE, J., KIM, Y.H., ALSINA MAQUEDA, M., LONGO MUNOZ, F., CERVANTES AGUILAR, A., ARANDA AGUILAR, E., GARCIA ALFONSO, P., RIVERA, F., FELIU BATLE, J., PAZO CID, R., YEH, K.H., CHEN, J.S., CHAO, Y., YEN, C.J., KARA, O., YALCIN, S., HOCHHAUSER, D., CHAU, I., BENSON, A., SHANKARAN, V., SHAIB, W., PHILIP, P., SHARMA, V., SIEGEL, R., SUN, W., WAINBERG, Z., GEORGE, B., BULLOCK, A., MYRICK, S., FARUOL, J., LARSON, T., BECERRA, C., RATNAM, S., RICHARDS, D.A., RICHE, S.L

in patients with a programmed cell death ligand 1 (PD-L1) combined positive score (CPS) of 1 or higher

PEMBROLIZUMAB VERSUS PACLITAXEL FOR PREVIOUSLY TREATED, ADVANCED GASTRIC OR GASTRO-OESOPHAGEAL JUNCTION CANCER (KEYNOTE-061): A RANDOMISED, OPEN-LABEL, CONTROLLED, PHASE 3 TRIAL

SHITARA, K., OHTSU, A., ÖZGÜROĞLU, M., BANG, Y.J., DI BARTOLOMEO, M., MANDALÀ, M., RYU, M.H.., FORNARO, L., OLESIŃSKI, T., CAGLEVIC, C., CHUNG, H.C., MURO, K., GOEKKURT, E., MANSOOR, W., MCDERMOTT, R.S., SHACHAM-SHMUELI, E., CHEN, X., MAYO, C., KANG, S.P., FUCHS, C.S., LERZO, G., O'CONNOR, J.M., MENDEZ, G.A., LYNAM, J., TEBBUTT, N., WONG, M., STRICKLAND, A., KARAPETIS, C., GOLDSTEIN, D., VASEY, P., VAN LAETHEM, J.L., VAN CUTSEM, E., BERRY, S., VINCENT, M., MULLER, B., REY, F., ZAMBRANO, A., GUERRA, J., KROGH, M., BAEKSGAARD, L., YILMAZ, M., ELME, A., MAGI, A., AUVINEN, P., ALANKO, T., MOEHLER, M., KUNZMANN, V., SEUFFERLEIN, T., THUSS-PATIENCE, P., HOEHLER, T., HAAG, G., AL-BATRAN, S.E., CASTRO, H., LOPEZ, K., AGUILAR VASQUEZ, M., SANDOVAL, M., LAM, K.O., CUFFE, S., KELLY, C., GEVA, R., HUBERT, A., BENY, A., BRENNER, B., GIUSEPPE, A., FALCONE, A., MAIELLO, E., PASSALACQUA, R., MONTESARCHIO, V., HARA, H., CHIN, K., NISHINA, T., KOMATSU, Y., MACHIDA, N., HIRONAKA, S., SATOH, T., TAMURA, T., SUGIMOTO, N., CHO, H., OMURO, Y., KATO, K., GOTO, M., HYODO, I., YOSHIDA, K., BABA, H., ESAKI, T., FURUSE, J., WAN MOHAMMED, W.Z., HERNANDEZ HERNANDEZ, C., CASAS GARCIA, J., DOMINGUEZ ANDRADE, A., CLARKE, K., HJORTLAND, G., GLENJEN, N., KUBIATOWSKI, T., JACEK, J., WOJTUKIEWICZ, M., LAZAREV, S., LANCUKHAY, Y., AFANASAYEV, S., MOISEYENKO, V., KOSTOROV, V., PROTSENKO, S., SHIRINKIN, V., SAKAEVA, D., FADEEVA, N., YONG, W.P., ROBERTSON, B., NG, C.H.M., ROBERTSON, B., RAPAPORT, B., COHEN, G., DREOSTI, L., RUFF, P., JACOBS, C., LANDERS, G., SZPAK, W., ROH, S.Y., LEE, J., KIM, Y.H., ALSINA MAQUEDA, M., LONGO MUNOZ, F., CERVANTES AGUILAR, A., ARANDA AGUILAR, E., GARCIA ALFONSO, P., RIVERA, F., FELIU BATLE, J., PAZO CID, R., YEH, K.H., CHEN, J.S., CHAO, Y., YEN, C.J., KARA, O., YALCIN, S., HOCHHAUSER, D., CHAU, I., BENSON, A., SHANKARAN, V., SHAIB, W., PHILIP, P., SHARMA, V., SIEGEL, R., SUN, W., WAINBERG, Z., GEORGE, B., BULLOCK, A., MYRICK, S., FARUOL, J., LARSON, T., BECERRA, C., RATNAM, S., RICHARDS, D.A., RICHE, S.L

in patients with a programmed cell death ligand 1 (PD-L1) combined positive score (CPS) of 1 or higher

A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina

Chaitman B.R., Ho A.P., Behm M.O., Rowe J.F., Palcza J.S., Laethem T., Heirman I., Panebianco D.L., Kobalava Z., Martsevich S.Y., Free A.L., Bittar N., Chrysant S.G., Ho T.W., Chodakewitz J.A., Murphy M.G., Blanchard R.L.

Trends over time in the incidence and use of hormonal therapy in endometrial cancer: A population-based study in the Netherlands

Van Weelden W.J., Van Erp S., Engels S., Pijnenborg J., Bretveld R., Van Der Aa M., Romano A., Lalisang R.

Modelling and mapping urban soils

Stoorvogel J.J., Van Manen I., Vasenev V.I.

ACCURACY OF HIV-1 SUBTYPE ASSIGNMENT OF V3 LOOP GP120 GENE

Марина Юрьевна Дмитрюкова, M. Y. Dmitryukova, Дмитрий Евгеньевич Киреев, D. E. Kireev, Алексей Эдуардович Лопатухин, A. E. Lopatukhin, Илья Андреевич Лаповок, I. A. Lapovok, Герман Александрович Шипулин, G. A. Shipulin

ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro

Oprea-Lager D.E., Hoekstra O.S., Geldof A.A., Bijnsdorp I.V., Van Moorselaar R.J.A., Van Den Eertwegh A.J.M.

Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction

Veenis J.F., Brugts J.J., Rocca H.P.B.L., Linssen G.C.M., Erol-Yilmaz A., Pronk A.C.B., Engelen D.J.M., Van Tooren R.M., Koornstra-Wortel H.J.J., De Boer R.A., Van der Meer P., Hoes A.W.

Фасеты

Новости проекта

Новости

Партнеры

Индексация